| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0003 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |